Reducing the Burden of Difficult-to-Treat Major Depressive Disorder | Zendy

Larry Culpepper | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Reducing the Burden of Difficult-to-Treat Major Depressive Disorder

Author(s) -

Larry Culpepper

Publication year - 2013

Publication title -

the primary care companion for cns disorders

Language(s) - English

Resource type - Journals

eISSN - 2155-7772

pISSN - 2155-7780

DOI - 10.4088/pcc.13r01515

Subject(s) - monoamine oxidase inhibitor , depression (economics) , medicine , serotonin syndrome , anxiety , psychiatry , transdermal , atypical depression , intensive care medicine , psychology , mood , monoamine oxidase , pharmacology , biochemistry , chemistry , receptor , serotonergic , serotonin , economics , macroeconomics , enzyme

Difficult-to-treat depression (eg, depression with atypical or anxious symptoms, treatment-resistant depression, or depression with frequent recurrence) is a challenging real-world health issue. This critical review of the literature focuses on monoamine oxidase inhibitor (MAOI) therapy and difficult-to-treat forms of depression.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research